Biomarkers in Clinical Trials, 20th & 21st September 2010, Central London
european cancer organisation swissbridge
ISSN: 1754-6605

News

Insider News

Insider News

Lung cancer genetics mapped

Published: 21/10/2008 - PDF Version (85 KB)

Genomics: Profiling lung cancer

A comprehensive analysis of the lung cancer genome is reported this week in Nature. By finding genes that are mutated in cancer cells compared with healthy cells, scientists are beginning to build a picture of what goes wrong to cause disease.

In a large multicentre study, Richard Wilson and colleagues examined genetic mutations associated with lung adenocarcinoma in 188 patient samples. Over 600 genes with known or potential links to the disease were sequenced, of which 26 were mutated at high frequencies.

The research identifies several genes that were not previously thought to be involved in lung cancer, roughly tripling the number of genes associated with this disease. These include genes that regulate the cell cycle and cell proliferation — ATM, APC, ERBB4 and FGFR4.

Overall the findings provide a road map of the signalling pathways gone awry in lung cancer, the leading cause of cancer death, and expand the range of potential therapeutic options.

Comments

11/11/2008 01:43:45
Comment by Lilja Halldorsdottir

Thank you for these news - one more step on the much too slow journey towards curing this horrible disease.



Unsuitable? Report this comment    


Also in the news

 

Post a comment

Your Details
Verification
  1. Please re-type the words exactly as shown below (this is for anti-spam purposes):

Follow us on Twitter
Submit Now
Editorial Profiles
Eurocancercoms. An exciting new project looking at the issues surrounding communication and dissemination of cancer information across Europe
call to advertise here +44 (0) 20 8544 1050